Clinical features of the complete closure of the ductus arteriosus prenatally

Congenital Heart Disease

Volumn 6, Issue 1, 2011, Pages 51-56

  Ishida, Hidekazu ^a,b   Inamura, Noboru ^a   Kawazu, Yukiko ^a   Kayatani, Futoshi ^a  

^a RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Ductus Arteriosus; Fetal Echocardiography; Persistent Pulmonary Hypertension

Indexed keywords

HYDROCORTISONE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ARTICLE; ARTIFICIAL VENTILATION; CASE REPORT; CLINICAL FEATURE; DOPPLER ECHOCARDIOGRAPHY; DUCTUS ARTERIOSUS OBLITERATION; ECHOCARDIOGRAPHY; FETUS; FETUS HYDROPS; HEART DILATATION; HEART RIGHT VENTRICLE PRESSURE; HUMAN; OXYGEN BREATHING; PERINATAL PERIOD; PRENATAL PERIOD; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TRICUSPID VALVE REGURGITATION;

ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CESAREAN SECTION; CONSTRICTION, PATHOLOGIC; DUCTUS ARTERIOSUS; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FETAL HEART; GESTATIONAL AGE; HUMANS; HYDROPS FETALIS; HYPERTROPHY, RIGHT VENTRICULAR; INFANT, NEWBORN; MATERNAL EXPOSURE; PERSISTENT FETAL CIRCULATION SYNDROME; PREGNANCY; TREATMENT OUTCOME; TRICUSPID VALVE INSUFFICIENCY; ULTRASONOGRAPHY, PRENATAL; YOUNG ADULT;

EID: 79251509587     PISSN: 1747079X     EISSN: 17470803     Source Type: Journal    
DOI: 10.1111/j.1747-0803.2010.00411.x     Document Type: Article

References (22)

1. Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev. 1998;50:35-58.
2. Conceani F, Olley PM. The response of the ductus arteriosus to prostaglandins. Can J Physiol Pharmacol. 1973;51:220-225.
3. Koren G, Florescu A, Costei AM, Boskovic R, Moretti ME. Nonsteroidal anti-inflammatory drugs during third trimester and the risk of premature closure of the ductus arteriosus: a meta-analysis. Ann Pharmacother. 2006;40:824-829.
4. Kondo T, Kitazawa R, Noda-Maeda N, Kitazawa S. Fetal hydrops associated with spontaneous premature closure of ductus arteriosus. Pathol Int. 2006;56:554-557.
5. Siu KL, Lee WH. Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension. J Paediatr Child Health. 2004;40:152-153.
6. Inamura N, Kado Y, Nakajima T, Kayatani F. Left and right ventricular function in fetal tetralogy of Fallot with absent pulmonary valve. Am J Perinatol. 2005;22:199-204.
7. Falkensammer CB, Paul J, Huhta JC. Fetal congestive heart failure: correlation of Tei index and cardiovascular score. J Perinat Med. 2001;29:390-398.
8. Respondek M, Respondek A, Huhta JC, Wilczynski J. 2D echocardiographic assessment of the fetal heart size in the 2nd and 3rd trimester of uncomplicated pregnancy. Eur J Obstet Gynecol Reprod Biol. 1992;44:185-188.
9. Momma K, Takeuchi H. Constriction of fetal ductus arteriosus by non-steroidal anti-inflammatory drugs. Prostaglandins. 1983;26:631-643.
10. Chao RC, Ho ES, Hsieh KS. Doppler echocardiographic diagnosis of intrauterine closure of the ductus arteriosus. Prenat Diagn. 1993;13:989-994.
11. Mielke G, Steil E, Breuer J, Goelz R. Circulatory changes following intrauterine closure of the ductus arteriosus in the human fetus and newborn. Prenat Diagn. 1998;18:139-145.
12. Mushiake K, Motoyoshi F, Kinoshita Y, Nakagawa A, Ito M. Severe heart failure due to ductal constriction caused by maternal indomethacin. Pediatr Int. 2002;44:174-176.
13. Siu KL, Lee WH. Maternal diclofenac sodium ingestion and severe neonatal pulmonary hypertension. J Paediatr Child Health. 2004;40:152-153.
14. Auer M, Brezinka C, Eller P, Luze K, Schweigmann U, Schwärzler P. Prenatal diagnosis of intrauterine premature closure of the ductus arteriosus following maternal diclofenac application. Ultrasound Obstet Gynecol. 2004;23:513-516.
15. Eronen M. The hemodynamic effects of antenatal indomethacin and a beta-sympathomimetic agent on the fetus and the newborn: a randomized study. Pediatr Res. 1993;33:615-619.
16. Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a beta-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol. 1991;164:141-146.
17. Moise KJ Jr, Huhta JC, Sharif DS, etal. Indomethacin in the treatment of premature labor. Effects on the fetal ductus arteriosus. N Engl J Med. 1988;319:327-331.
18. Leal SD, Cavallé-Garrido T, Ryan G, Farine D, Heilbut M, Smallhorn JF. Isolated ductal closure in utero diagnosed by fetal echocardiography. Am J Perinatol. 1997;14:205-210.
19. Kondo T, Kitazawa R, Noda-Maeda N, Kitazawa S. Fetal hydrops associated with spontaneous premature closure of ductus arteriosus. Pathol Int. 2006;56:554-557.
20. Abman SH, Accurso FJ. Acute effects of partial compression of ductus arteriosus on fetal pulmonary circulation. Am J Physiol. 1989;257:H626-H634.
21. Morin FC 3rd, Egan EA. The effect of closing the ductus arteriosus on the pulmonary circulation of the fetal sheep. J Dev Physiol. 1989;11:283-287.
22. Gewillig M, Brown SC, De Catte L, etal. Premature foetal closure of the arterial duct: clinical presentations and outcome. Eur Heart J. 2009;30:1530-1536.